AI Assistant
Blog
Pricing
Log In
Sign Up
The Emerging Monoclonal Antibodies (mAbs) targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and Hypercholetrolemia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
